@JohnCFierce: The FDA's suvorexant decision was expected. I don't see how weak suvo competes with the generics. It'll be an alternative for non-response. | Follow @JohnCFierce
@RyanMFierce: Onyx is following the M&A resistance strategy, which Termeer and more recently Martin have used. More | Follow @RyanMFierce
> Pharming has completed a tech transfer deal with a subsidiary of China's Sinopharm. They'll work jointly on new drug development projects. Story
> Cambridge, MA-based Alnylam ($ALNY) says it reaped positive clinical results from its Phase II trial of ALN-TTR02, an RNAi therapeutic targeting the transthyretin gene for the treatment of TTR-mediated amyloidosis. Release
> The CEO of Melbourne-based Phosphagenics has reportedly been suspended pending an investigation into "irregular transactions." Story
> Bayer and partner Onyx ($ONXX) have submitted a supplemental NDA to the FDA seeking an OK to use Nexavar as a treatment for thyroid cancer. Release
Medical Device News
@FierceMedDev: Veracyte nails $28M Series C. Story | Follow @FierceMedDev
@MarkHFierce: There's still time to submit your nomination for this year's FMD Fierce 15. More | Follow @MarkHFierce
@DamianFierce: Thoratec is spending up to $56.5M for Terumo's in-development heart device. News | Follow @DamianFierce
> Malaysia's new device regs poised to heighten the competition. Article
> A drug-free Covidien is now all about devices. Story
> Zyomyx pulls in $12M to advance low-cost HIV Dx to finish line. More
Pharma News
@FiercePharma: Fresenius Kabi yanks four lots of benztropine mesylate on risk of glass particles, stops distribution to investigate. News | Follow @FiercePharma
@EricPFierce: ICYMI: FDA approves first non-hormonal treatment for hot flashes. Release | Follow @EricPFierce
> Merck KGaA sees U.S. as "emerging market" for sales growth. More
> Pfizer, Bristol-Myers tout new VTE data on Eliquis, aiming for new use. News
CRO News
> MMS teams up with Datatrak for eClinical heft. Story
> Want to work with Roche? Prepare for high standards. More
> AstraZeneca taps Sarah Cannon for cancer R&D. Article
Biotech IT News
> Ex-Googlers bring Big Data analytics to oncology. News
> Deloitte turns EHR reservoir into health outcomes tool. Article
> J&J teams up with Mount Sinai on bioinformatics project. Story
> Data secrecy and outdated tech exacerbating drug shortages. More
And Finally… A new study concludes that people who regularly smoke marijuana produce less dopamine in the brain, which could be connected to lowered motivation. Release